<img height="1" width="1" src="https://www.facebook.com/tr?id=257515398000723&amp;ev=PageView &amp;noscript=1">

About AGS

Advanced Genomic Solutions (AGS) is an expert and industry pioneer in integrating genomic testing into personal health management. Founded in Scottsdale, Arizona, AGS began commercializing genetic testing in 2012 and aims to empower all its clients and physicians with accurate genetic data.
This actionable genetic information enables clients to make smarter lifestyle choices in improving health and revolutionizes the way to customize nutrition, dietary and fitness needs to one's personal biology.

Since 1997, AGS’s American executives have successfully launched hundreds of advanced medical products in China, South East Asia, United States and India. AGS executives have initiated the commercialization and implementation of pharmacogenomics into physician practices. Cutting edge breakthroughs and scientific advances are being translated into personalized solutions for everyday life.

AGS adheres to strict confidentiality and privacy laws that ensure all genetic information is kept private or only shared with your physician. Unlike several other genetic companies, AGS does not sell or transfer any personal data to any third parties. No exceptions.

The AGS state-of-the-art laboratory is CLIA-registered (CLIA ID# 99D2143058), and our testing relies on industry-standard chemistry and protocols from Thermo Fisher Scientific, and is independently validated by partner laboratories on a continuing basis.

AGS offers multiple genomic tests:
  • Health & Wellness
  • Personalized Medicine
  • Caris Molecular Intelligence® tumor profiling
  • HLA drug hypersensitivity


Before entering the genomic market and building a new state-of-the-art laboratory in Central, Hong Kong, AGS conducted two years of due diligence on the South East Asia genetic market. In doing so, we have numerous key partnerships with major medical practices and have sold thousands of genetic tests worldwide.

CLIA Logo.jpeg

Our Science

Based on the results from the Human Genome Project (HGP), an international thirteen-year project that began in October 1990, AGS began evaluating specific SNPs identified within its report. The projects' focus was to sequence and map the entire human genome (full set of genes present in the human body). Completed in 2003, the HGP findings gave us the ability to read nature’s complete genetic blueprint for human beings. Based on this solid foundation, AGS further examines DNA to develop new ways to treat, cure, or even prevent the thousands of diseases that afflict humankind.




Why Choose AGS

AGS operate with the fundamental business ethic of complete transparency. This means the full, accurate, and timely disclosure of information. We approach the genomics industry from a position of personal empowerment and privacy. We do not claim ownership of the sample collected nor the analysis we run on it including the resulting inforamtion. 

Our process is simple with no hidden agendas or conditions.

Our Vision and Mission

AGS aims to empower all our clients and physicians with unique and actionable genetic data enabling smarter lifestyle choices.